Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Gujarat Inject (Kerala) Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Gujarat Inject (Kerala) Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 May 2026, 1:39PM Media Release on Audited Financial for Results for Q4 FY26.
  • Guj. Inject(Kera Q4 net profit zooms 2242.86% at Rs 1.64 cr

    20 May 2026, 7:20PM The company reported standalone net profit of Rs 1.64 crore for the quarter ended March 31, 2026 as compared to Rs 0.07 crore in the same period last
  • Guj. Inject(Kera - Results - Financial Results For 31/03/2026

    20 May 2026, 7:05PM Financial Results for the quarter and year ended on 31/03/2026.
  • Guj. Inject(Kera - Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday, 20Th May, 2026 And Submission Of

    20 May 2026, 7:00PM Pursuant to Regulations 30, 33 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby
  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Change in Directorate

    16 May 2026, 7:19PM Appointment of Whole Time Director and Chairman of the company w.e.f. 16/05/2026.
  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Resignation of Chairman and Managing Director

    16 May 2026, 7:16PM Resignation of Managing Director and chairman of the company w.e.f. 16/05/2026.
  • Guj. Inject(Kera - Board Meeting Intimation for Board Meeting For Consideration Of Audited Financial Results For The Quarter

    15 May 2026, 7:56PM Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to conside
  • Guj. Inject(Kera has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    21 Apr 2026, 5:00PM As of March 2026, 100.00% owned by Public. <p align=justify>
  • Gujarat Inject Kerala bags Rs 3.11 crore Solar Module Order from Earthwave Technology

    27 Mar 2026, 11:48AM Gujarat Inject Kerala Limited has received a purchase order from Earthwave Technology Private Limited for the supply of 3,645 units of Solar PV Module
  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    27 Mar 2026, 11:34AM The Company has received a Purchase Order from EARTHWAVE TECHNOLOGY PRIVATE LIMITED for 3645 NOS Solar PV Module. Total Value is around 3.11 Crores (e
  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    27 Mar 2026, 11:30AM The Company has received a Purchase Order from PERFECT RENEWTECH PRIVATE LIMITED for 1355 NOS Solar PV Module. Total Value is around 1.21 Crores (excl
  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    27 Mar 2026, 11:26AM The Company has received a Purchase Order from EARTHWAVE TECHNOLOGY PRIVATE LIMITED for 4056 NOS Solar PV Module. Total Value is around 3.49 Crores (e
  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    16 Mar 2026, 12:08PM The Company has received a Purchase order from SURJA INFRA PRIVATE LIMITED for 678 NOS of Solar Module.\r\nTotal value is around 0.61 Crores(Exclusive
  • Guj. Inject(Kera - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    16 Mar 2026, 12:03PM The Company has received a Purchase Order from EARTHWAVE TECHNOLOGY PRIVATE LIMITED For 7041 NOS Solar PV Module .\r\nTotal Value is around 6.067 Cror

Key fundamentals

Evaluate the intrinsic value of Gujarat Inject (Kerala) Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 11.8298 10.0124 8.5453 -0.2298 -0.1441
Liabilities 11.8298 10.0124 8.5453 -0.2298 -0.1441
Equity 14.6348 14.6348 11.2923 4.8848 4.8848
Gross Profit 2.308 1.0751 0.0448 -0.3771 -0.0452
Net Profit 1.8141 1.0171 0.0827 0.041 0.0022
Cash From Operating Activities 21.2201 -1.5465 -6.0276 0.0526 -0.0002
NPM(%) 4.99 5.34 1.42 23.59 9.77
Revenue 36.3204 19.0457 5.7883 0.1738 0.0226
Expenses 34.0124 17.9706 5.7434 0.5509 0.0678
ROE(%) 17.77 9.96 0.81 0.4 0.02

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Gujarat Inject (Kerala) Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 721.75 0.85 0.00 63.21 -26.19 0.70
Lotus Eye Hospital and Institute Ltd 108.90 -1.89 3610.00 230.32 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.53 1.10 0.00 478.22 -39.50 0.00
Astec Lifesciences Ltd 753.50 1.24 0.00 217.20 -363.15 0.00

Company Info

Gujarat Inject (Kerala) Limited (GIKL) was incorporated on 7th January, 1991 and obtained Certificate for Commencement of Business on 14th February, 1991. The Company has been jointly promoted by the Kerala State Industrial Development Corporation Limited(KSIDC), a wholly owned subsidiary of Government of Kerala Undertaking and Gujarat Inject Limited (GIL) and its associates. GIL is a profit making dividend paying company. The Company has received SIA Registration to manufacture intravenous solutions at Puddussey East, Kanjikode, in Palghat District in Kerala. b) MAIN OBJECTS OF THE COMPANY The main object of the Company as set out fully in the Memorandum of Association of the Company are to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation,intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits. The immediate object of the Company is to set up a project for manufacture of intravenous (IV) Fluids solutions in aspectic bottles. Gujarat Inject (Kerala) Limited (GIKL) is promoted in the joint sector by Gujarat Inject Limited (GIL), Baroda and its associates along with the Kerala State Industrial Development Corporation Limited (KSIDC) a wholly owned subsidiary of the Government of Kerala.

Gujarat Inject (Kerala) Limited (GIKL) was incorporated on 7th January, 1991 and obtained Certificate for Commencement of Business on 14th February, 1991. The Company has been jointly promoted by the Kerala State Industrial Development Corporation Limited(KSIDC), a wholly owned subsidiary of Government of Kerala Undertaking and Gujarat Inject Limited (GIL) and its associates. GIL is a profit making dividend paying company. The Company has received SIA Registration to manufacture intravenous solutions at Puddussey East, Kanjikode, in Palghat District in Kerala. b) MAIN OBJECTS OF THE COMPANY The main object of the Company as set out fully in the Memorandum of Association of the Company are to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation,intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits. The immediate object of the Company is to set up a project for manufacture of intravenous (IV) Fluids solutions in aspectic bottles. Gujarat Inject (Kerala) Limited (GIKL) is promoted in the joint sector by Gujarat Inject Limited (GIL), Baroda and its associates along with the Kerala State Industrial Development Corporation Limited (KSIDC) a wholly owned subsidiary of the Government of Kerala.

Read More

Parent Organisation

Gujarat Inject (Kerala) Ltd.

Founded

07/01/1991

Managing Director

Mr.Murli Nair

NSE Symbol

FAQ

The current price of Gujarat Inject (Kerala) Ltd is

The 52-week high for Gujarat Inject (Kerala) Ltd is

The market capitalization of Gujarat Inject (Kerala) Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Gujarat Inject (Kerala) Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Gujarat Inject (Kerala) Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gujarat Inject (Kerala) Ltd shares.

The CEO of Gujarat Inject (Kerala) Ltd is Mr.Murli Nair, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT